Thornburg Investment Management Inc. Has $13.03 Million Holdings in Tenet Healthcare Corporation $THC

Thornburg Investment Management Inc. trimmed its holdings in Tenet Healthcare Corporation (NYSE:THC) by 3.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,183 shares of the company’s stock after selling 2,243 shares during the period. Thornburg Investment Management Inc. owned 0.07% of Tenet Healthcare worth $13,032,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. William B. Walkup & Associates Inc. bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at $32,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the 2nd quarter valued at about $35,000. Westside Investment Management Inc. lifted its holdings in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after acquiring an additional 96 shares during the period. Trust Co. of Vermont acquired a new position in Tenet Healthcare during the third quarter valued at approximately $41,000. Finally, True Wealth Design LLC lifted its stake in Tenet Healthcare by 238.2% during the second quarter. True Wealth Design LLC now owns 257 shares of the company’s stock worth $45,000 after purchasing an additional 181 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Insider Buying and Selling

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.81% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently commented on THC. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. JPMorgan Chase & Co. raised their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Morgan Stanley reissued an “overweight” rating and issued a $260.00 price objective on shares of Tenet Healthcare in a research note on Thursday, February 12th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. Finally, Wall Street Zen downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 21st. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average price target of $247.67.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $237.13 on Thursday. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $240.83. The firm has a market cap of $20.62 billion, a PE ratio of 15.31, a price-to-earnings-growth ratio of 1.16 and a beta of 1.44. The firm’s fifty day moving average is $204.26 and its 200-day moving average is $198.96.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. During the same period last year, the company earned $3.44 EPS. Tenet Healthcare’s revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.